Literature DB >> 20427982

Acute kidney injury and 2009 H1N1 influenza-related critical illness.

Rinaldo Bellomo, Ville Pettilä, Steven A R Webb, Michael Bailey, Belinda Howe, Ian M Seppelt.   

Abstract

The year 2009 was characterized by a pandemic with a new virus, the 2009 H1N1 influenza virus. This pandemic was responsible for thousands of deaths worldwide, many more hospital admissions, and thousands of admissions to intensive care units (ICUs). Among those admitted to ICUs, the pandemic was associated with a mortality of approximately 16%, a high incidence of acute lung injury and, in some cases, acute respiratory distress syndrome severe enough to require support with extracorporeal membrane oxygenation. As part of such a critical illness, a percentage of patients developed acute kidney injury (AKI) which complicated their clinical course and, in some patients, required support by renal replacement therapy. In a case series from Mexico, the incidence of severe AKI was reported in about 30% of the patients. Similarly, at the Austin Hospital, of 13 cases, 8 developed AKI with 3 being classified in the failure category of the RIFLE classification. Among the patients with AKI, hospital mortality was approximately 25%. Of the AKI patients, 3 (37.5%) received renal replacement therapy and, among these, 1 died. In a case of severe AKI and multi-organ failure from whom histological material was obtained, the renal histopathological findings were typical of acute tubular necrosis. One patient who suffered from hypoxic brain injury due to cardiac arrest at home secondary to H1N1 pneumonia became a kidney and liver donor. There was no evidence of viral infiltration on kidney biopsy and the recipient did not develop H1N1 infection. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20427982     DOI: 10.1159/000313771

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  6 in total

Review 1.  Renal complications of seasonal and pandemic influenza A virus infections.

Authors:  Toru Watanabe
Journal:  Eur J Pediatr       Date:  2012-10-13       Impact factor: 3.183

2.  Clinical Profile and Predictors of Mortality of Severe Pandemic (H1N1) 2009 Virus Infection Needing Intensive Care: A Multi-Centre Prospective Study from South India.

Authors:  Kartik Ramakrishna; Sriram Sampath; Jose Chacko; Binila Chacko; Deshikar L Narahari; Hemanth H Veerendra; Mahesh Moorthy; Bhuvana Krishna; Vs Chekuri; Rama Krishna Raju; Devika Shanmugasundaram; Kishore Pichamuthu; Asha M Abraham; Oc Abraham; Kurien Thomas; Prasad Mathews; George M Varghese; Priscilla Rupali; John V Peter
Journal:  J Glob Infect Dis       Date:  2012-07

3.  Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection.

Authors:  Ignacio Martin-Loeches; Elisabeth Papiol; Alejandro Rodríguez; Emili Diaz; Rafael Zaragoza; Rosa María Granada; Lorenzo Socias; Juan Bonastre; Montserrat Valverdú; Juan Carlos Pozo; Pilar Luque; Jose Antonio Juliá-Narvaéz; Lourdes Cordero; Antonio Albaya; Daniel Serón; Jordi Rello
Journal:  Crit Care       Date:  2011-02-22       Impact factor: 9.097

4.  Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients.

Authors:  Ignacio Martin-Loeches; Emili Díaz; Loreto Vidaur; Antoni Torres; Cesar Laborda; Rosa Granada; Juan Bonastre; Mar Martín; Josu Insausti; Angel Arenzana; Jose Eugenio Guerrero; Ines Navarrete; Jesus Bermejo-Martin; David Suarez; Alejandro Rodriguez
Journal:  Crit Care       Date:  2011-11-28       Impact factor: 9.097

Review 5.  Prevalence and mortality due to acute kidney injuries in patients with influenza A (H1N1) viral infection: A systemic narrative review.

Authors:  Sultan Al Dalbhi; Hassan Ali Alshahrani; Ahmad Almadi; Hamza Busaleh; Mohammed Alotaibi; Wejdan Almutairi; Zahra Almukhrq
Journal:  Int J Health Sci (Qassim)       Date:  2019 Jul-Aug

6.  Severe virus influenza A H1N1 related pneumonia and community-acquired pneumonia: differences in the evolution.

Authors:  Paula Nardocci; Caio Eduardo Gullo; Suzana Margareth Lobo
Journal:  Rev Bras Ter Intensiva       Date:  2013 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.